183 Keith Green, Smoking vs Cannabinoids for Glaucoma 116 Archives of Opthalmology 1433. ‘Marijuana Therapy’ (1998) 184 A J (THC) in the Treatment of End-stage Open-angle (2002) 100 Transactions of the Flach, ‘Delta-9-tetrahydrocannabinol Glaucoma’ American Opthalmological Society 215. 185 See, eg, Keith Green, Smoking vs Cannabinoids for Glaucoma 116 Archives of Opthalmology 1433. ‘Marijuana Therapy’ (1998) 186 Keith Green, Smoking vs Cannabinoids for Glaucoma 116 Archives of Opthalmology 1433. The author refers ‘Marijuana Therapy’ (1998) to treatments such as once- or twice-a-day eye drops (blockers such as timolol maleate, or the prostaglandin agonist latanoprost). 187 Ibid. 188 I Tomida, R G Pertwee and A Azuara-Blanco, and 88 British Journal of Opthalmology 708, 711. ‘Cannabinoids Glaucoma’ (2004) 43 189 American Glaucoma Society, Position Statement on Marijuana and the Treatment of Glaucoma (10 August 2009) <americanglaucomasociety.net>.
183 Keith Green, ‘Marijuana Smoking vs Cannabinoids for Glaucoma Therapy’ (1998) 116 Archives of Opthalmology 1433. 184 A J Flach, ‘Delta-9-tetrahydrocannabinol (THC) in the Treatment of End-stage Open-angle Glaucoma’ (2002) 100 Transactions of the American Opthalmological Society 215. 185 See, eg, Keith Green, ‘Marijuana Smoking vs Cannabinoids for Glaucoma Therapy’ (1998) 116 Archives of Opthalmology 1433. 186 Keith Green, ‘Marijuana Smoking vs Cannabinoids for Glaucoma Therapy’ (1998) 116 Archives of Opthalmology 1433. The author refers to treatments such as once- or twice-a-day eye drops (blockers such as timolol maleate, or the prostaglandin agonist latanoprost). 187 Ibid. 188 I Tomida, R G Pertwee and A Azuara-Blanco, ‘Cannabinoids and Glaucoma’ (2004) 88 British Journal of Opthalmology 708, 711. 189 American Glaucoma Society, Position Statement on Marijuana and the Treatment of Glaucoma (10 August 2009) <americanglaucomasociety.net>. 43
VLRC_Medicinal_Cannabis_Report_web.docx